12:00 AM
 | 
Oct 11, 1999
 |  BC Week In Review  |  Clinical News  |  Regulatory

Visudyne verteporfin regulatory update

The FDA's Ophthalmic Drugs Subcommittee of the Dermatologic and Ophthalmic Drugs Advisory Committee will review on...

Read the full 58 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >